Guest guest Posted July 15, 2008 Report Share Posted July 15, 2008 With only five months to go until the phase-out of CFC propellants for albuterol inhalers, the FDA notes that up to 55% of inhaler users have still not transitioned to HFA medications. "As respiratory therapists, it's time to act and make sure our patients are educated and aware of the changes that will occur," said Tom Kallstrom, Chief Operating Officer of the AARC. http://aarc.org/headlines/08/06/inhaler_phaseout/ Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.